Home › Diffuse Large B-Cell Lymphoma › Texas › Dallas
Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Dallas, TX
Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Nagre-recruitPhase 3
- Texas Oncology - DFW ( Site 8000), Dallas
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Nagre-recruitPhase 2
- UT Southwestern Medical Center ( Site 0190), Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Nagre-recruitPhase 2
- University of Texas Southwestern Medical Center, Dallas
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Nagre-recruitPhase 1
- University of Texas Southwestern, Dallas
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Nagre-recruitPhase 1
- Texas Oncology - DFW (Sammons CC), Dallas
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Nagre-recruitPhase 2
- Texas Oncology - Dallas Fort Worth, Dallas
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Nagre-recruitPhase 1/2
- Baylor University Medical Center, Dallas
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Nagre-recruitObservasyonal na pag-aaral
- UT Southwestern Medical Center, Dallas
DALY II USA/ MB-CART2019.1 for DLBCL
Nagre-recruitPhase 2
- UT Southwestern Medical Center, Dallas
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
Nagre-recruitPhase 1/2
- University of Texas Southwestern Medical Center, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
Nagre-recruitPhase 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Nagre-recruitPhase 1
- University of Texas Southwestern Medical Center, Dallas
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
Nagre-recruitPhase 1/2
- UT Southwestern Medical Center, Dallas
Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod
- New York City, NY20 pag-aaral
- Baldwin Park, CA19 pag-aaral
- Los Angeles, CA18 pag-aaral
- Houston, TX18 pag-aaral
- Chicago, IL18 pag-aaral
- Milwaukee, WI17 pag-aaral
- Nashville, TN17 pag-aaral
- Boston, MA17 pag-aaral
- Philadelphia, PA15 pag-aaral
- Durham, NC15 pag-aaral
- Portland, OR15 pag-aaral
- Cleveland, OH13 pag-aaral
Iba pang pag-aaral sa Dallas
- Kanser sa Suso54 pag-aaral
- Non-Small Cell Lung Cancer53 pag-aaral
- Metastatic Cancer44 pag-aaral
- Pagkabigo ng Puso42 pag-aaral
- Kanser (lahat ng uri)40 pag-aaral
- Kanser sa Prostate39 pag-aaral
- Colorectal Cancer34 pag-aaral
- Obesity33 pag-aaral
- Kanser sa Ovary31 pag-aaral
- Kanser sa Pantog27 pag-aaral
- Kanser sa Baga26 pag-aaral
- Kanser ng Endometrium25 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.